Membership-Based Association
As a membership-based association, GINN engages with stakeholders globally to promote an evidence-based, science-led approach to protecting and advancing the novel nicotine sector.
Global Advocacy
GINN tackles regulatory challenges, fosters innovation, and supports research to ensure that novel nicotine products achieve their potential in harm reduction and public health.
Setting the Standard
GINN is committed to maintaining high standards across regulatory compliance, youth access prevention, responsible marketing, and product quality. By setting rigorous standards, we prioritize integrity and consumer safety.
Research and Innovation
We support ongoing research that validates the benefits and safety of novel nicotine products, continuously driving improvements in product development.
Public Health Impact
We aim to communicate the health benefits of switching from combustible tobacco to RRPs, advocating for better public health outcomes.
Leading the Way
GINN's Science and Standards Committee
The Science and Standards Committee (SSC) is central to GINN’s approach, chaired by experts in toxicology and regulatory sciences. This committee develops regulatory guidelines to enhance product safety and public health standards.
Core Principles
GINN’s core principles include commitments to youth access prevention, ethical marketing, responsible flavor naming, and environmental sustainability. Our code of conduct ensures members uphold these values with integrity.
Evidence-Based Advocacy
Our advocacy across the UK, EU, and North America is grounded in scientific research, strengthening our positions on novel nicotine products and their role in harm reduction.
Advancing Understanding
We support studies and independent reviews that explore the roles novel nicotine products play in smoking cessation. GINN champions innovation to improve product safety and consumer satisfaction.
Industry Engagement and Events
GINN participates in global industry conferences, symposiums, and events, as well as hosting its own conferences. These platforms allow us to advocate for novel nicotine products to a wide range of stakeholders.
